Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.

FEBS letters - 16 Oct 1995

Chao C C

Abstract excerpt

A multidrug-resistant (MDR) subline of the immunoblastic B lymphoma cell line was established by sequentially selecting in increasing concentrations of adriamycin. The adriamycin-resistant cell line (HOB1/ADR) demonstrated resistance to a wide spectrum of chemotherapeutic agents including MDR drugs (Vinca alkaloids and anthracycline), antimicrotubule drug (colchicine), and DNA-damaging agents (cisplatin and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Base Sequence
Share to Cell Division
Share to Gene Expression

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Molecular Sequence Data

Share to Phenotype

Share to Polymerase Chain Reaction

Share to RNA, Messenger

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 7589484
DOI: 10.1016/0014-5793(95)01063-k

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lack of elevated drug efflux in adriamycin-resistant immunoblastic B lymphoma cells with mdr1 overexpression.PMID 7589484Read ↗

Characterization of vincristine-resistant HOB1 lymphoma cell line showing the classical MDR phenotype and altered expression of membrane glycoproteins.Semantic proximity Read ↗

ABCB1/MDR1 contributes to the anticancer drug-resistant phenotype of IPH-926 human lobular breast cancer cells.Semantic proximity Read ↗

Reduced drug accumulation and multidrug resistance in human breast cancer cells without associated P-glycoprotein or MRP overexpression.Semantic proximity Read ↗

A human B-cell lymphoma line with a de novo multidrug resistance phenotype.Semantic proximity Read ↗

MDR-1 gene expression is a minor factor in determining the multidrug resistance phenotype of MCF7/ADR and KB-V1 cells.Semantic proximity Read ↗

Characterization of a multidrug-resistant chronic myeloid leukemia cell line presenting multiple resistance mechanisms.Semantic proximity Read ↗

Establishment of doxorubicin-resistant human bladder cancer cell line (BUI-87/ADMR) and its mechanism of multidrug resistance.Semantic proximity Read ↗

MDR1/P-Glycoprotein (ABCB1) as Target for RNA Interference-Mediated Reversal of Multidrug ResistanceSemantic proximity Read ↗

A mutation hot spot in the Bcrp1 (Abcg2) multidrug transporter in mouse cell lines selected for Doxorubicin resistance.Semantic proximity Read ↗

Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.Semantic proximity Read ↗

Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.Semantic proximity Read ↗

Relating multidrug resistance phenotypes to the kinetic properties of their drug-efflux pumps.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.